Literature DB >> 8474033

Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice.

D O Freier1, B A Fuchs.   

Abstract

Morphine has been reported to possess immunosuppressive actions in both in vitro as well as in vivo assays of immune function. Our work in female B6C3F1 mice, surgically implanted with a 75-mg time release morphine pellet, has confirmed previous reports of a rapid loss in the cellularity of the spleen and thymus. To evaluate the effect of morphine on the subpopulations of cells in the thymus, two color fluorescence flow cytometry studies were performed. Fluorescently conjugated monoclonal antibodies specific for the murine cell surface CD4 and CD8 markers were used to identify the four major subpopulations of thymocytes. These studies indicated that morphine pellet-implanted mice suffered a loss in each of the four thymocyte subpopulations in comparison to placebo-implanted mice. However, the loss (> 90%) in the important CD4+/CD8+ subpopulation of immature thymocytes greatly exceeded that which was observed for any other subpopulation. Kinetic studies of morphine's effect on the thymocyte subpopulations revealed that the maximal depletion of the CD4+/CD8+ cells occurs approximately 4 days after pellet implantation. Thymocyte cell populations recovered by 14 days, with an increase above placebo for the double positive cells. Naltrexone administration blocked thymic alterations, suggesting that these immunologic consequences of morphine may be mediated through an opiate receptor. Measurements in thymocytes from morphine pellet-implanted mice showed an increased level of DNA fragmentation, whereas in vitro exposure to morphine (1-100 microM) produced no such increases. This suggests morphine may be working indirectly to induce apoptosis of immature thymocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474033

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 2.  Effects of opioids on the immune system.

Authors:  S Roy; H H Loh
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

3.  Depletion and recovery of lymphoid subsets following morphine administration.

Authors:  E Y Zhang; J Xiong; B L Parker; A Y Chen; P E Fields; X Ma; J Qiu; T M Yankee
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.

Authors:  Virginia D McLane; Ivy Bergquist; James Cormier; Deborah J Barlow; Karen L Houseknecht; Edward J Bilsky; Ling Cao
Journal:  Life Sci       Date:  2017-07-16       Impact factor: 5.037

5.  Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.

Authors:  P di Francesco; R Gaziano; I A Casalinuovo; L Belogi; A T Palamara; C Favalli; E Garaci
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

6.  Regulation of mu opioid receptor expression in developing T cells.

Authors:  Lily Zhang; Judith Sliker Belkowski; Tammi Briscoe; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

7.  Close apposition of dynorphin-positive nerve fibres to lymphocytes in the liver suggests opioidergic neuroimmunomodulation.

Authors:  Matthias J T Kaiser; Gisa Tiegs; Winfried L Neuhuber
Journal:  Histochem Cell Biol       Date:  2003-08-05       Impact factor: 4.304

8.  Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.

Authors:  Sudheesh Pilakka-Kanthikeel; Venkata Subba Rao Atluri; Vidya Sagar; Shailendra K Saxena; Madhavan Nair
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

9.  Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.

Authors:  Marianne Strazza; Anupam Banerjee; Aikaterini Alexaki; Shendra R Passic; Olimpia Meucci; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  BMC Res Notes       Date:  2014-10-23

10.  The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysis.

Authors:  Mats Enlund; Anders Berglund; Kalle Andreasson; Catharina Cicek; Anna Enlund; Leif Bergkvist
Journal:  Ups J Med Sci       Date:  2014-05-26       Impact factor: 2.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.